Episoder
-
Mangler du episoder?
-
Today’s podcast features a discussion with leading experts Harry Erba, MD, PhD, Duke University, Durham, NC, Farhad Ravandi, MD, The...
The post Prolonging remission in AML: current approaches & future outlooks appeared first on VJHemOnc.
-
Welcome to the final episode of VJHemOnc’s Blood Cancer Awareness Month special series! This episode focuses on the role of...
The post A focus on the use of artificial intelligence to personalize blood cancer care appeared first on VJHemOnc.
-
Welcome to the third episode of VJHemOnc’s Blood Cancer Awareness Month special series! The focus of this episode is pediatric...
The post A focus on pediatric leukemias: trials, treatments, & challenges appeared first on VJHemOnc.
-
Welcome to the second episode of VJHemOnc’s Blood Cancer Awareness Month special series! Today’s episode focuses on the psychosocial impacts...
The post A focus on the psychosocial impacts of living with blood cancer appeared first on VJHemOnc.
-
In myelodysplastic syndromes (MDS), chronic inflammation driven by the innate immune system plays a key role in disease progression. Signal...
The post Inflammation and immune interventions in MDS: targeting STAT, IRAK4, & more appeared first on VJHemOnc.
-
Today’s VJHemOnc podcast features experts Rabi Hanna, MD, The Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, Subarna Chakravorty, MBBS, MRCPCH,...
The post Updates in the treatment of SCD and thalassemia from EHA 2024: key trial updates, challenges with gene therapies & unmet needs appeared first on VJHemOnc.
-
Myelofibrosis (MF) is a chronic myeloproliferative neoplasm (MPN) characterized by bone marrow fibrosis, extramedullary hematopoiesis, and splenomegaly, often resulting in...
The post Unmet treatment needs in MF: managing prefibrotic disease & thrombocytopenia, novel agents & endpoints for clinical trials appeared first on VJHemOnc.
-
In today’s VJHemOnc podcast, we will be sharing novel developments in lower-risk myelodysplastic syndromes (LR-MDS) and important practical considerations when treating patients....
The post Novel developments in lower-risk MDS & important practical considerations when treating patients appeared first on VJHemOnc.
-
BCMA-targeting bispecific antibodies treat multiple myeloma by binding to BCMA on malignant plasma cells and directing T-cells to initiate targeted...
The post Updates on the use of BCMA-targeting bispecific antibodies in R/R multiple myeloma: insights from EHA & ASCO 2024 appeared first on VJHemOnc.
-
Welcome to today’s VJHemOnc podcast episode, where we will be sharing key highlights from the 2024 International Symposium on Amyloidosis...
The post Highlights from ISA 2024: the importance of early diagnosis in AL amyloidosis, trials in progress & patient selection for SCT appeared first on VJHemOnc.
- Se mer
